MSB 4.39% $1.09 mesoblast limited

Hey guys I just wanted to create a thread discussing some of the...

  1. 208 Posts.
    lightbulb Created with Sketch. 133
    Hey guys I just wanted to create a thread discussing some of the differences between Ryoncil and Jakafi trial results prior to approval/rejection from the fda. From what I understand Novartis did a single arm trial with only a small number of patients prior to approval due to it demonstrating approx 69% overall response rate vs around 30% in the standard care group however there were significant adverse events such as thrombocytopenia, anaemia and cytomegalovirus etc. I get that Jakafi was already approved for other conditions and has a defined MOA but how can you turn down Ryoncil and not Jakafi with their relative safety profiles. Why can’t mesoblast perform a retrospective study on their patients in Japan and use that to support efficacy etc
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.050(4.39%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.14 $1.17 $1.07 $8.385M 7.489M

Buyers (Bids)

No. Vol. Price($)
1 8500 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 26954 3
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.